Indaptus Therapeutics
INDP
20 hedge funds and large institutions have $1.16M invested in Indaptus Therapeutics in 2020 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 1 reducing their positions, and 6 closing their positions.
500% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 1
67% more call options, than puts
Call options by funds: $5K | Put options by funds: $3K
4.25% less ownership
Funds ownership: 15.5% → 11.24% (-4.3%)
20% less funds holding
Funds holding: 25 → 20 (-5)
57% less capital invested
Capital invested by funds: $2.71M → $1.16M (-$1.55M)
67% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PF
Phoenix Financial
Givatayim,
Israel
|
+$154K |
| 2 |
Renaissance Technologies
New York
|
+$93.7K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$30.2K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$27.2K |
| 5 |
Morgan Stanley
New York
|
+$12.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HIIFS
Harel Insurance Investments & Financial Services
Ramat Gan,
Israel
|
-$124K |
| 2 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$11K |
| 3 |
TSS
Two Sigma Securities
New York
|
-$7K |
| 4 |
Group One Trading
Chicago,
Illinois
|
-$6.8K |
| 5 |
HKAM
Horizon Kinetics Asset Management
New York
|
-$5K |
INDP Hedge Fund Activity: Q1 2020 in Review
20 of the 4,547 institutional investors tracked by Wall St. Rank reported a position in Indaptus Therapeutics (INDP) for Q1 2020, worth a combined $1.16M — down 57% from $2.71M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of INDP and 2 opened new positions — a net loss of 4 holders — while 1 trimmed existing stakes and 6 added.
The largest buyer was Phoenix Financial, adding an estimated $154K. The largest seller was Harel Insurance Investments & Financial Services, exiting entirely with an estimated $124K sold.
- 20 institutional investors held Indaptus Therapeutics (INDP) as of Q1 2020, down from 25 in Q4 2019.
- Funds reported $1.16M of Indaptus Therapeutics stock for Q1 2020, down 57% quarter-over-quarter.
- 2 funds opened new Indaptus Therapeutics positions in Q1 2020 and 6 closed out, a net change of -4 holders.
- The largest Indaptus Therapeutics buyer in Q1 2020 was Phoenix Financial, an estimated $154K added.
- The largest Indaptus Therapeutics seller in Q1 2020 was Harel Insurance Investments & Financial Services, an estimated $124K sold.
Based on aggregated 13F filings for Q1 2020.